Cargando…
An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients
Germline genetics, gender and hormonal-signaling pathways are all well described modifiers of cancer risk and progression. Although an improved understanding of how germline genetic variants interact with other cancer risk factors may allow better prevention and treatment of human cancer, measuring...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276689/ https://www.ncbi.nlm.nih.gov/pubmed/18398474 http://dx.doi.org/10.1371/journal.pone.0001951 |
_version_ | 1782152008715730944 |
---|---|
author | Atwal, Gurinder Singh Rabadán, Raúl Lozano, Guillermina Strong, Louise C. Ruijs, Mariëlle W. G. Schmidt, Marjanka K. van't Veer, Laura J. Nevanlinna, Heli Tommiska, Johanna Aittomäki, Kristiina Bougeard, Gaelle Frebourg, Thierry Levine, Arnold J. Bond, Gareth L. |
author_facet | Atwal, Gurinder Singh Rabadán, Raúl Lozano, Guillermina Strong, Louise C. Ruijs, Mariëlle W. G. Schmidt, Marjanka K. van't Veer, Laura J. Nevanlinna, Heli Tommiska, Johanna Aittomäki, Kristiina Bougeard, Gaelle Frebourg, Thierry Levine, Arnold J. Bond, Gareth L. |
author_sort | Atwal, Gurinder Singh |
collection | PubMed |
description | Germline genetics, gender and hormonal-signaling pathways are all well described modifiers of cancer risk and progression. Although an improved understanding of how germline genetic variants interact with other cancer risk factors may allow better prevention and treatment of human cancer, measuring and quantifying these interactions is challenging. In other areas of research, Information Theory has been used to quantitatively describe similar multivariate interactions. We implemented a novel information-theoretic analysis to measure the joint effect of a high frequency germline genetic variant of the p53 tumor suppressor pathway (MDM2 SNP309 T/G) and gender on clinical cancer phenotypes. This analysis quantitatively describes synergistic interactions among gender, the MDM2 SNP309 locus, and the age of onset of tumorigenesis in p53 mutation carriers. These results offer a molecular and genetic basis for the observed sexual dimorphism of cancer risk in p53 mutation carriers and a model is proposed that suggests a novel cancer prevention strategy for p53 mutation carriers. |
format | Text |
id | pubmed-2276689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-22766892008-04-09 An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients Atwal, Gurinder Singh Rabadán, Raúl Lozano, Guillermina Strong, Louise C. Ruijs, Mariëlle W. G. Schmidt, Marjanka K. van't Veer, Laura J. Nevanlinna, Heli Tommiska, Johanna Aittomäki, Kristiina Bougeard, Gaelle Frebourg, Thierry Levine, Arnold J. Bond, Gareth L. PLoS One Research Article Germline genetics, gender and hormonal-signaling pathways are all well described modifiers of cancer risk and progression. Although an improved understanding of how germline genetic variants interact with other cancer risk factors may allow better prevention and treatment of human cancer, measuring and quantifying these interactions is challenging. In other areas of research, Information Theory has been used to quantitatively describe similar multivariate interactions. We implemented a novel information-theoretic analysis to measure the joint effect of a high frequency germline genetic variant of the p53 tumor suppressor pathway (MDM2 SNP309 T/G) and gender on clinical cancer phenotypes. This analysis quantitatively describes synergistic interactions among gender, the MDM2 SNP309 locus, and the age of onset of tumorigenesis in p53 mutation carriers. These results offer a molecular and genetic basis for the observed sexual dimorphism of cancer risk in p53 mutation carriers and a model is proposed that suggests a novel cancer prevention strategy for p53 mutation carriers. Public Library of Science 2008-04-09 /pmc/articles/PMC2276689/ /pubmed/18398474 http://dx.doi.org/10.1371/journal.pone.0001951 Text en Bond et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Atwal, Gurinder Singh Rabadán, Raúl Lozano, Guillermina Strong, Louise C. Ruijs, Mariëlle W. G. Schmidt, Marjanka K. van't Veer, Laura J. Nevanlinna, Heli Tommiska, Johanna Aittomäki, Kristiina Bougeard, Gaelle Frebourg, Thierry Levine, Arnold J. Bond, Gareth L. An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients |
title | An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients |
title_full | An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients |
title_fullStr | An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients |
title_full_unstemmed | An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients |
title_short | An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients |
title_sort | information-theoretic analysis of genetics, gender and age in cancer patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276689/ https://www.ncbi.nlm.nih.gov/pubmed/18398474 http://dx.doi.org/10.1371/journal.pone.0001951 |
work_keys_str_mv | AT atwalgurindersingh aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT rabadanraul aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT lozanoguillermina aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT stronglouisec aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT ruijsmariellewg aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT schmidtmarjankak aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT vantveerlauraj aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT nevanlinnaheli aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT tommiskajohanna aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT aittomakikristiina aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT bougeardgaelle aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT frebourgthierry aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT levinearnoldj aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT bondgarethl aninformationtheoreticanalysisofgeneticsgenderandageincancerpatients AT atwalgurindersingh informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT rabadanraul informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT lozanoguillermina informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT stronglouisec informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT ruijsmariellewg informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT schmidtmarjankak informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT vantveerlauraj informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT nevanlinnaheli informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT tommiskajohanna informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT aittomakikristiina informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT bougeardgaelle informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT frebourgthierry informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT levinearnoldj informationtheoreticanalysisofgeneticsgenderandageincancerpatients AT bondgarethl informationtheoreticanalysisofgeneticsgenderandageincancerpatients |